Embeda and Drowsiness - a phase IV clinical study of FDA data

Summary:

Drowsiness is reported as a side effect among people who take Embeda (morphine sulfate; naltrexone hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Oxycodone, and have Pain.

The phase IV clinical study analyzes which people have Drowsiness when taking Embeda. It is created by eHealthMe based on reports of 1,394 people who have side effects when taking Embeda from the FDA, and is updated regularly.

What is Embeda?

Embeda has active ingredients of morphine sulfate; naltrexone hydrochloride. eHealthMe is studying from 1,407 Embeda users. Check the latest studies of Embeda.

What is Drowsiness?

Drowsiness is found to be associated with 2,865 drugs and 4,797 conditions by eHealthMe. Check the latest studies of Drowsiness.

On Jun, 15, 2026

1,394 people reported to have side effects when taking Embeda.
Among them, 54 people (3.87%) have Drowsiness.

Among these 54 people:

How long have people been on Embeda when they have Drowsiness? *

What is the gender of people who have Drowsiness when taking Embeda? *

female: 62.5 %
male: 37.5 %

What is the age of people who have Drowsiness when taking Embeda? *

What are other drugs people take besides Embeda? *

What are other side effects people have besides Drowsiness? *

Pain: 17 people, 31.48%
Nausea (feeling of having an urge to vomit): 14 people, 25.93%
Dizziness: 12 people, 22.22%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 11 people, 20.37%
Fatigue (feeling of tiredness): 11 people, 20.37%
Nausea And Vomiting: 11 people, 20.37%
Malaise (a feeling of general discomfort or uneasiness): 10 people, 18.52%
Drug Ineffective: 9 people, 16.67%
Oedema Peripheral (superficial swelling): 9 people, 16.67%
Constipation: 8 people, 14.81%

What are the existing conditions these people have? *

Pain: 13 people, 24.07%
Depression: 11 people, 20.37%
Back Pain: 10 people, 18.52%
Cushing's Syndrome (obesity, a rounded face, increased fat): 7 people, 12.96%
Breakthrough Pain: 7 people, 12.96%
Joint Pain: 6 people, 11.11%
High Blood Cholesterol: 6 people, 11.11%
Binge Eating (pattern of disordered eating which consists of episodes of uncontrollable eating): 6 people, 11.11%
High Blood Pressure: 5 people, 9.26%
Sleep Disorder: 4 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Embeda and have Drowsiness?

- Check whether Drowsiness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Embeda:

Embeda (1,407 reports)

Drowsiness treatments and more:

Drowsiness (269,040 reports)

How severe was Drowsiness and when was it recovered:

Drowsiness in Embeda

Expand to all the drugs that have ingredients of morphine sulfate; naltrexone hydrochloride:

Drowsiness and drugs with ingredients of morphine sulfate; naltrexone hydrochloride

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Embeda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drowsiness:

Drowsiness (2,865 drugs)

Browse all the conditions that are associated with Drowsiness:

Drowsiness (4,797 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate; naltrexone hydrochloride (the active ingredients of Embeda) and Embeda (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.